A New Treatment Strategy that Reduces Growth/Differentiation Factor-15 in Type-2 Diabetes Mellitus: Major Autohemotherapy: A Pilot Study
Growth/differentiation factor-15 (GDF-15) is a diagnostic and prognostic marker associated with inflammation, renal damage, and cardiovascular risk in type-2 diabetes mellitus. Researchers have proposed treatment targets that reduce GDF-15 levels. Our aim in this study is to investigate the effect o...
Saved in:
Published in | Alternative therapies in health and medicine Vol. 29; no. 7; pp. 30 - 33 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
InnoVision Health Media, Inc
01.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!